INGN Stock Recent News

While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Inogen (INGN) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $0.38 per share a year ago.

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19, 2023 at 12:45 p.m. Eastern Time.

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Inogen's (INGN) fourth-quarter results benefit from higher revenues in its domestic business-to-business sales channel.

Inogen Inc. (NASDAQ:INGN ) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Matthew Blackman - Stifel Michael Matson - Needham & Company Operator Greetings. Welcome to the Inogen 2022 Fourth Quarter Financial Results.

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Inogen's (INGN) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its product sales.

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.